JLK, Inc. (KOSDAQ:322510)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,890.00
-460.00 (-6.26%)
Mar 9, 2026, 3:30 PM KST
-11.33%
Market Cap 174.91B
Revenue (ttm) 3.26B
Net Income (ttm) -11.00B
Shares Out 25.39M
EPS (ttm) -439.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 360,547
Average Volume 729,685
Open 7,180.00
Previous Close 7,350.00
Day's Range 6,700.00 - 7,180.00
52-Week Range 3,965.00 - 8,670.00
Beta 1.72
RSI 45.73
Earnings Date May 13, 2026

About JLK, Inc.

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, ... [Read more]

Industry Conglomerates
Sector Industrials
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 322510
Full Company Profile

Financial Performance

In 2024, JLK, Inc.'s revenue was 1.43 billion, a decrease of -42.65% compared to the previous year's 2.49 billion. Losses were -13.45 billion, 83.7% more than in 2023.

Financial Statements

News

There is no news available yet.